What Is Keeping Community Oncology Providers Up at Night?

Community oncology practices are critical to the delivery of cancer care in the United States, treating about 80%, of patients. (~40% in community clinics and ~40% in community hospitals).

Providing top-quality care in the community setting has unique challenges, including keeping pace with the accelerating innovation in cancer care (13 novel drugs and additional 67 indication expansions approvals in 2023 alone) while treating a widely diverse patient population, navigating increasingly complex non-clinical prescribing decision influencing factors (e.g., U.S. managed care organization (MCO) medical benefit management, pathways, protocols) and ensuring sustainable financial models for these mostly independent practices throughout dynamic changes.

To aid in elevating the voice of community oncology in the United States, Trinity Life Sciences recently engaged with ~50 leaders of diverse U.S. community oncology practices during the national meeting of Cornerstone Specialty Network, an organization that provides long-term, sustainable value through a collaborative network of community-based oncology practices.

This whitepaper highlights key insights from that engagement with the intent of amplifying community oncology perspectives on addressing key opportunities and the challenges and concerns they face for 2024 and beyond.

Complete the form below to access the full white paper

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.